http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101983880-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 |
filingDate | 2013-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101983880-B1 |
titleOfInvention | Novel benzazepine derivative and pharmaceutical use thereof |
abstract | It is an object of the present invention to provide a compound having a V2 receptor agonistic action. (I): < EMI ID = [Chemical Formula 1] Wherein R 1 is a group represented by the formula: (2) (Wherein A represents a lower alkylene group which may be substituted by a lower alkyl group, R 6 represents a hydrogen atom, R 7 represents a hydrogen atom, a hydroxyl group, an aromatic heterocyclic group which may be substituted by a lower alkyl group, Bamboo Diary) Etc .; R 2 represents a hydrogen atom or a lower alkyl group; R 3 is 1 - 3 Quot; means a lower alkyl group or a halogen atom which may be substituted with one or two fluorine atoms; R 4 is a 5-membered aromatic monocyclic heterocyclic group or a 5-membered non-aromatic monocyclic heterocyclic group (provided that such a heterocyclic group contains at least one nitrogen atom and may be substituted with a lower alkyl group); R < 5 > represents a lower alkyl group or a halogen atom or the like] ≪ / RTI > or a pharmaceutically acceptable salt thereof as an active ingredient. |
priorityDate | 2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 526.